Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Oct
16
2022
Biden-Harris Administration Continues to Invest in Rural Health Care Improvements in Montana U.S. Department of Agriculture
Oct
15
2022
Honduran National Indicted for International Cocaine Trafficking Extradited from Honduras to the United States The U.S. Department of Justice
Oct
14
2022
Presidential Pardon for Simple Marijuana Possession Leaves Out Many Jackson Lewis P.C.
Oct
14
2022
CSB Recommends EPA Initiate Prioritization under TSCA to Evaluate Whether Hydrofluoric Acid Is a High-Priority Substance Bergeson & Campbell, P.C.
Oct
14
2022
MOAH in Food: New October Statement Poses Broader Issues for Operators in the Food and Food Contact Materials Supply Chain in EU Keller and Heckman LLP
Oct
14
2022
NIFA Will Hold RFA Technical Assistance Webinar on Biotechnology Risk Assessment Research Grants Bergeson & Campbell, P.C.
Oct
14
2022
Five New Employment Laws that Every California Employer Should Know Proskauer Rose LLP
Oct
13
2022
FDA Webinar Series on Infant Formula Transition Plan Keller and Heckman LLP
Oct
13
2022
Four Years After EKRA: Reminders for Clinical Laboratories Epstein Becker & Green, P.C.
Oct
13
2022
If California's Pork Law Falls, Will Section 2115 Be Next? Allen Matkins Leck Gamble Mallory & Natsis LLP
Oct
13
2022
Long Live the Kingpin: No Abandonment Based on Nonuse During Drug Sanctions Period McDermott Will & Emery
Oct
13
2022
JBCE Proposes Harmonization of the Classification of MWCNTs Bergeson & Campbell, P.C.
Oct
13
2022
OIG Limits Pharmaceutical Manufacturers’ Ability to Offer Drug Cost-Sharing Subsidies Sheppard, Mullin, Richter & Hampton LLP
Oct
13
2022
Four Years After Enactment – Clinical Laboratories Should Not Forget About EKRA Epstein Becker & Green, P.C.
Oct
13
2022
So You Want to Be a Cannabis Lawyer? Bradley Arant Boult Cummings LLP
Oct
12
2022
BREAKING: Plaintiff Prevails In First BIPA Class Action Jury Trial Squire Patton Boggs (US) LLP
Oct
12
2022
FDA Issues Final Guidance on Clinical Decision Support Technology with Implications for Software Developers and Providers Polsinelli PC
Oct
12
2022
FDA Launches Study on the Role of Seafood Consumption in Child Development Keller and Heckman LLP
Oct
12
2022
Takeaways from President Biden’s Announcement on Marijuana Policy Reform Foley & Lardner LLP
Oct
11
2022
APHIS Issues RSR Responses under Revised Biotechnology Regulations Bergeson & Campbell, P.C.
Oct
11
2022
Court Rejects Challenge to USDA’s New Swine Slaughter Inspection Rule Keller and Heckman LLP
Oct
11
2022
Biden’s Statement on Marijuana Reform: What Does it Mean? Womble Bond Dickinson (US) LLP
Oct
11
2022
California Passes New Law Requiring Physicians and their Employers to Notify Patients about the Open Payments Database Mintz
Oct
10
2022
Regulatory Roundup: Important FDA Developments at the End of September 2022 Mintz
Oct
7
2022
Legalized Cannabis in Missouri: What Employers Need to Know Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Oct
7
2022
Healthcare Regulatory Check-Up | September 2022 McDermott Will & Emery
Oct
7
2022
California Expands Employees’ Right to Off-Duty Cannabis Use Sheppard, Mullin, Richter & Hampton LLP
Oct
7
2022
APHIS BRS Will Hold Annual Stakeholder Meeting on December 8, 2022 Bergeson & Campbell, P.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins